Category Archives: Paperless Lab
At NL42 we are extremely pleased with the results and feedback received after the recent acquisition of the event’s organization ( Press Release)
The event is dedicated to companies needing to adopt a paperless approach in their scientific data management throughout the product life cycle.
We decided to focus this year’s edition on the Internet of Lab things (IoLT) with the title “2020 Roadmap for Digital Convergence – transforming scientific information into actionable insight“.
The event consists of a balanced mix of plenary and workshop sessions. Read More...
Exchange of ideas at the PAPERLESS LAB ACADEMY 2016 Strengthens its success
The Paperless Lab Academy 2016, held on 19 and 20 April in Barcelona, closed its doors again with many positive impressions, from visitors of the industry, suppliers and sponsors.
Innovation, cloud, data integrity and process improvement were the key topics in this edition.
Among the presentations , we highlight the contribution of Michael Shandler, Research Vice President, Life Science R&D en Gartner who described the event as one of the best in its category. Michael Shandler opened the event with his vision Read More...
Paperless Lab Transformation Process Training
The pre-congress workshop at the Paperless Lab Academy 2016 lead by NL42 has allowed to introduce the concept of designing a paperless laboratory
The training has received great acceptance and positive feedbacks on the relevance of such initiative. We´re glad to communicate that we´ve decided to run a new session by beginning of October in Madrid.
Should you be interested please contact directly isabel.munoz@nl42.com
On Monday April 18th, at the Don Jaime Hotel in Castelldefels (Barcelona), we launched the Paperless Lab Week with Read More...
R&D Process reengineering at FAES FARMA
COLLABORATION FAES FARMA and NL42: BUSINESS PROCESS RE-ENGINEERING PROJECT IN THE R&D DEPARTMENT
Faes Farma, a Spanish pharmaceutical company founded in 1933, with a strong presence in Spain and Portugal and a growing international presence, currently totalling 45 countries and exporting raw materials and finished pharmaceutical products to more than 60 countries.
As a result of its commitment to pharmaceutical research, Faes Farma can highlight the recent launch of an antihistamine molecule –Bilastine-, commercialised in Spain since 2011, currently marketed in Read More...